Human TFPI ELISA Kit (with Control)

* Varadi K et al. (2016) Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA in prophylactic therapy. Haemophilia. 22(4):615-24

• http://onlinelibrary.wiley.com/doi/10.1111/hae.12873/full

* Uyanik MS (2014) Tissue factor pathway inhibitor and thrombin-activatable carboxypeptidase B for prediction of early atherosclerosis in gouty arthritis. Thromb Res. 134(2):526-30

• https://pubmed.ncbi.nlm.nih.gov/24974054/#affiliation-1

* Sosothikul D et al. (2012) Reference values for thrombotic markers in children. Blood Coagul Fibrinolysis. 23(3):208-11.

• https://www.ncbi.nlm.nih.gov/pubmed/22322138

* Xiong Y et al. (2011) Alternations of Maternal and Cord Plasma Hemostasis in Preeclampsia Before and After Delivery. Hypertens Pregnancy. 30(3):347-358

• https://www.tandfonline.com/doi/abs/10.3109/10641950903572274?journalCode=ihip20

* Teng YC et al. (2009) Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J. Perinat. Med. 37(4):343-348

• https://pubmed.ncbi.nlm.nih.gov/19290852/#affiliation-1

* Wang JS et al. (2007) Exercise Modulates Platelet-Nasopharyngeal Carcinoma Cell Aggregation and Subsequent Tissue Factor and Matrix Metalloproteinase Activities. J Appl Physiol 149(4):187-195

• http://jap.physiology.org/content/103/3/763

* Mousa SA et al. (2007) Pharmacokinetics and Pharmacodynamics of Oral Heparin Solid Dosage Form in Healthy Human Subjects. J Clin Pharmacol. 47(12):1508-20

• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135515/

* Schernthaner GH et al. (2006) No effect of homocysteine-lowering therapy on vascular inflammation and haemostasis in peripheral arterial occlusive disease. Eur J Clin Invest 36(5):333-339

• https://pubmed.ncbi.nlm.nih.gov/16634837/